Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.75
-0.14 (-2.38%)
Nov 20, 2024, 4:00 PM EST - Market open
Abeona Therapeutics Employees
Abeona Therapeutics had 84 employees as of December 31, 2023. The number of employees increased by 27 or 47.37% compared to the previous year.
Employees
84
Change (1Y)
27
Growth (1Y)
47.37%
Revenue / Employee
n/a
Profits / Employee
-$845,619
Market Cap
254.59M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Zynex | 1,100 |
Lifecore Biomedical | 524 |
Anika Therapeutics | 357 |
Poseida Therapeutics | 330 |
Fate Therapeutics | 181 |
Atea Pharmaceuticals | 75 |
Ocugen | 65 |
Eton Pharmaceuticals | 30 |
ABEO News
- 7 days ago - Abeona Therapeutics® Reports Third Quarter 2024 Financial Results and Recent Corporate Updates - GlobeNewsWire
- 9 days ago - Abeona Therapeutics® Announces FDA Acceptance of BLA Resubmission of Pz-cel for the Treatment of Recessive Dystrophic Epidermolysis Bullosa - GlobeNewsWire
- 17 days ago - Abeona Therapeutics® Announces Participation in November Investor Conferences - GlobeNewsWire
- 20 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 23 days ago - Abeona Therapeutics® Completes Pz-cel Biologics License Application Resubmission to U.S. Food and Drug Administration - GlobeNewsWire
- 7 weeks ago - Abeona Therapeutics Targets RDEB Market With Promising Pz-cel Therapy - Seeking Alpha
- 2 months ago - Abeona Therapeutics® Announces Participation in Upcoming Investor Conferences - GlobeNewsWire
- 3 months ago - Abeona Therapeutics® Announces Appointment of Bernhardt Zeiher, MD, FCCP, FACP, and Eric Crombez, MD to its Board of Directors - GlobeNewsWire